Monash University, Australia
Plecomacrolide vacuolar-ATPase inhibitor bafilomycin alters insulin signaling in MIN6 beta cells
Published in Law and Health Weekly, July 8th, 2006
According to a study from Australia, "Inhibition of endosomal acidification disturbs insulin signaling in both liver and adipose cells. In this study we used MIN6 beta cells to determine whether bafilomycin, a potent inhibitor of the proton-translocating vacuolar ATPase, disrupts insulin signaling in islet beta cells."
K.D. Hettiarachchi and colleagues at Monash University explained, "Pretreatment of MIN6 cells with varying concentrations of bafilomycin according to a time course revealed concentration and time-dependent changes in phosphorylation of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Awards
Humana wins Stevie Award for best new product - Baylor College of Medicine, U.S.
Ethics for clinical trials enrollment for women of childbearing potential emphasized - Bradmer Pharmaceuticals
Bradmer extends patent portfolio with allowance letter from European Patent Office - Business Update
USIS Commercial Services launches I-9 Employment Eligibility Verification Product - Cerimon Pharmaceuticals
Cerimon Pharmaceuticals names James Welch as chief financial officer - Cytopia
Cytopia announces major license and R&D collaboration - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
